combinational therapy
Showing 1 - 25 of >10,000
Combinational Immunotherapy, Hepatocellular Carcinoma Non-Resectable, Hyperbaric Oxygen Therapy Trial in Wuhan (hyperbaric
Recruiting
- Combinational Immunotherapy
- +2 more
- hyperbaric oxygen therapy plus Camrelizumab
-
Wuhan, Hubei, ChinaHepatic Surgery Center, Tongji Hospital, Huazhong University of
Jan 23, 2022
Head and Neck Squamous Cell Carcinoma, Skin Cancer, Metastatic Head-and-neck Squamous-cell Carcinoma Trial in Jerusalem
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +2 more
- Diffusing Alpha Radiation Emitters Therapy (DaRT)
- Pembrolizumab
-
Jerusalem, IsraelSharett institute, Hadassah University Hospital - Ein-Kerem
Nov 8, 2021
Breast Cancer, Breast Cancer Female Trial in China (surufatinib + fulvestrant + chidamide)
Not yet recruiting
- Breast Cancer
- Breast Cancer Female
- surufatinib + fulvestrant + chidamide
-
Anyang, China
- +4 more
Jul 18, 2022
Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)
Recruiting
- Hepatocellular Carcinoma
- Durvalumab
- +2 more
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023
Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)
Recruiting
- Recurrent Non-small Cell Lung Cancer
- Cisplatin
- +7 more
-
Changchun, Jilin, China
- +2 more
May 3, 2022
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Cell Carcinoma Trial (LioCyx-M, Lenvatinib)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- LioCyx-M
- Lenvatinib
- (no location specified)
Jan 4, 2022
Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Relapsed Leukemia Trial in
Not yet recruiting
- Lymphoblastic Leukemia, Acute, Childhood
- +3 more
- Olverembatinib, APG-2575, Dexamethasone
-
Hefei, Anhui, China
- +3 more
Aug 8, 2022
Tinea Cruris, Tinea Pedis Trial in United States (UHE-103 Cream, Naftin (naftifine HCl) Cream)
Recruiting
- Tinea Cruris
- Tinea Pedis
- UHE-103 Cream
- Naftin (naftifine hydrochloride) Cream
-
San Diego, California
- +4 more
May 2, 2022
Non Small Cell Lung Cancer Trial in Innsbruck (neoadjuvant therapy with Pembrolizumab/Lenvatinib, Surgery, Adjuvant Treatment
Recruiting
- Non Small Cell Lung Cancer
- neoadjuvant therapy with Pembrolizumab/Lenvatinib
- +2 more
-
Innsbruck, Tirol, AustriaMedical University Innsbruck
Aug 23, 2022
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
Recruiting
- Hepatocellular Carcinoma
- Anti-angiogenic agents plus anti-PD-1/PD-L1 antibodies
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Jul 23, 2021
Large B-cell Lymphoma Trial in Tianjin (CNCT19, Gemcitabine Injection, busulfan)
Recruiting
- Large B-cell Lymphoma
- CNCT19
- +3 more
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jan 24, 2022
Lung Cancer, Non-small Cell, EGFR T790M, EGFR Gene Mutation Trial in Shanghai (Almonertinib, Pemetrexed, Carboplatin)
Unknown status
- Lung Cancer, Non-small Cell
- +2 more
- Almonertinib
- +2 more
-
Shanghai, Shanghai, ChinaCancer hospital Fudan University
Oct 15, 2020
Tinnitus Trial in Regensburg (Structured counseling, Hearing aids, Cognitive behavioral therapy)
Recruiting
- Tinnitus
- Structured counseling
- +3 more
-
Regensburg, Bavaria, GermanyTinnituszentrum Regensburg
Aug 25, 2021
Cancer of Pancreas Trial in Los Angeles (Nutrawell Powder, Diet Only, OmegaRich fish oil supplement)
Terminated
- Cancer of Pancreas
- Nutrawell Powder
- +2 more
-
Los Angeles, CaliforniaUCLA Department of Medicine Center for Human Nutrition
Aug 1, 2022
Acne Trial in Madison (5% Topical Benzoyl Peroxide Gel, Blue Light Therapy)
Completed
- Acne
- 5% Topical Benzoyl Peroxide Gel
- Blue Light Therapy
-
Madison, WisconsinUniversity of Wisconsin - Madison
Apr 13, 2022
Chronic Lymphoid Leukemia in Relapse Trial in Tuebingen (Belimumab 200 MG/ML [Benlysta], standard of care)
Recruiting
- Chronic Lymphoid Leukemia in Relapse
- Belimumab 200 MG/ML [Benlysta]
- standard of care
-
Tuebingen, BW, GermanyUniversity Hospital Tuebingen, CCU Translational Immunology
Feb 2, 2022
B-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CART/CTL and DCvac)
Recruiting
- B-Cell Acute Lymphoblastic Leukemia
- Antigen-specific T cells CART/CTL and DCvac
-
Shenzhen, Guangdong, ChinaShenzhen Geno-Immune Medical Institute
Mar 7, 2022
T-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CAR-T/CTL and DCvac)
Recruiting
- T-Cell Acute Lymphoblastic Leukemia
- Antigen-specific T cells CAR-T/CTL and DCvac
-
Shenzhen, Guangdong, ChinaShenzhen Geno-immune Medical Institute
Mar 14, 2022
Infertility Trial in Peshawar (Acetyl-l-carnitine, folic acid)
Completed
- Infertility
- Acetyl-l-carnitine, folic acid
-
Peshawar, Khyber Pakhtunkha, PakistanMohsin Shah, PhD
Nov 29, 2022
Diabetes, Type 1, Hypoglycemia, Autoimmune Diseases Trial in Miami (Anti-Thymocyte Globulin (ATG), Interleukin 2, Exenatide)
Not yet recruiting
- Diabetes Mellitus, Type 1
- +3 more
- Anti-Thymocyte Globulin (ATG)
- +7 more
-
Miami, FloridaDiabetes Research Institute, University of Miami Miller School o
Feb 23, 2022
Spinal Cord Injuries, Stroke, Paralysis Trial in Kowloon (trans-spinal Electrical Stimulation (tsES))
Completed
- Spinal Cord Injuries
- +2 more
- trans-spinal Electrical Stimulation (tsES)
-
Kowloon, Hong KongDepartment of Biomedical Engineering, The Hong Kong Polytechnic
Jan 5, 2022
Brain Injury, Cognition, PTSD Trial in Gainesville (Goal Management Training plus Attention Training, Brain Health Workshop and
Recruiting
- Brain Injury
- +3 more
- Goal Management Training plus Attention Training
- Brain Health Workshop and National Geographic Movies
-
Gainesville, FloridaNorth Florida/South Georgia Veterans Health System, Gainesville,
Nov 10, 2022
Chronic Lymphocytic Leukemia Trial in Tuebingen (Multipeptide Vaccine+ XS15)
Recruiting
- Chronic Lymphocytic Leukemia
- Multipeptide Vaccine+ XS15
-
Tuebingen, BW, Germany
- +1 more
Sep 7, 2021